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CHRONIC ISCHAEMIC HEART DISEASE
Transthoracic Doppler echocardiography (TTE) is the pre-
ferred tool for the diagnosis and follow-up of patients with
chronic ischaemic heart disease. TTE enables repeated
study of global and regional left ventricular systolic func-
tion, left ventricular remodelling and its consequences,
analysis of left ventricular filling and assessment of pulmo-
nary pressures. The investigation therefore provides consi-
derable useful information to adjust medical treatment,
monitor evolution and assess prognosis. Systematic control
of these parameters is useful in patients with abnormal left
ventricular systolic function even if no clinical changes
have occurred. Conversely, clinical symptoms guide the fre-
quency of Doppler echocardiography controls in patients
with good left ventricular function.
Resting Doppler echocardiography 
Left ventricular geometry and function (table 1)
Left ventricular morphology. 
Investigation for left intraventricular thrombus 
(cf acute coronary syndrome chapter)
The global morphology of the left ventricle is assessed by
two-dimensional echocardiography. Ventricular diameters
are measured systematically, in M-mode with long axis
parasternal or subcostal views. 
Global left ventricular remodelling can be assessed by
measuring volumes (Simpson biplane rule) and by measu-
ring the sphericity indices obtained in systole and diastole
(ratio of maximum length of the left ventricle to its width
in the apical view) [1-4].
Left ventricular aneurysm is characterised by deformity
of the diastolic outline in an akinetic or dyskinetic area
with a thin wall. The functional value of the residual normal
myocardium must be stated [5].
The investigation should always seek to identify a left intra-
ventricular thrombus. This is particularly common as a sequela
to anterior or apical infarction with an apical aneurysm [6]
(table 2).
Left ventricular systolic function
The assessment of regional left ventricular function involves
describing akinetic or hypokinetic areas in different views,
describing their extent, morphological features and segmen-
tal wall thickness. A thin (diastolic thickness <6 mm) and
dense appearance of akinetic myocardium indicates fibrous
scarring and is highly predictive of lack of viability [7].
Estimation of left ventricular ejection fraction (LVEF) by
two-dimensional echocardiography is part of the routine
investigation. The resting LVEF is the most important pro-
gnostic indicator in patients with chronic ischaemic heart
disease and plays an important role in treatment decisions,
including consideration for cardiac resynchronisation [8, 9].
Semi-quantitative visual assessment of the LVEF has the
major limitation of limited reproducibility, particularly for
low LVEF. LVEF is best measured by the modified Simpson
biplane method using harmonic imaging. This method also
has limitations in detecting the left ventricular endocar-
dium or left ventricular dilatation. Other techniques which
are not used routinely improve the repeatability and repro-
ducibility of measurements, such as the use of intravenous
contrast agents [10] or real time transthoracic three-
dimensional echocardiography, which has recently been
introduced [11].
Left ventricular filling pressures (table 3)
(cf recommendations on the echocardiographic
assessment of cardiomyopathies) 
Evaluation of diastolic function is essential. This enables fil-
ling pressures to be measured and provides prognostic
information. 
Transmitral flow analysis by pulsed Doppler is performed
routinely. An E wave deceleration time of <150 msec and/or
E/A ratio of >2 support raised left ventricular filling pressures
in the presence of left ventricular systolic dysfunction [12-16].
Other parameters need to be recorded if mitral flow is “nor-
mal” in appearance: Ea wave measurement by tissue Doppler
at the annulus with calculation of the E/Ea ratio; pulmonary
vein flow by pulsed Doppler (Ap-Am time); left ventricular
flow propagation during early filling by colour M-mode (Vp).
Functional mitral regurgitation 
Functional mitral regurgitation is often found in heart
failure. It is dynamic in nature and may increase or reduce
as a result of changes in left ventricular size, geometry and
load conditions. Left ventricular dilatation causes apical
and lateral displacement of the papillary muscles,
increasing the papillary muscle — valve annulus distance
[17]. Increased tension on the cordae is responsible for
valve restriction, apical displacement of the closure point
and reduced closure surface area resulting in an increase in
the surface area between the mitral cusps and the annulus
in mid-systole (area under the tent) and the height of the
closure point. These geometrical and contractile changes
cause imbalance between the traction and closure forces
on the mitral valve. During ventricular systole, the mitral
valve is subjected to two competing forces: closure forces
which are represented by left intraventricular pressure and
by systolic contraction of the annulus (reducing the annulus
surface area to be covered by the mitral cusps) and the
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traction forces which oppose the closure forces by restric-
ting valve movements in systole (and which occur as a
result of the force exerted on the mitral cusps by cordae
tendineae and by annulus dilatation) [17].
Increase in mitral regurgitation as a result of physical exer-
cise in patients with heart failure adds to restricting exercise
capacity and is associated with a poor prognosis [18-20]. These
dynamic changes are often accompanied by an increase in pul-
monary arterial systolic pressure and are associated with
changes in valve geometry and the dynamic nature of asyn-
chronism [21, 22].
Right cavities, pulmonary pressures 
and right ventricular filling pressures (table 4)
Analysis of the right cavities involves a morphological assess-
ment of the cavities, right ventricle and atrium, pulmonary
artery, superior vena cava and suprahepatic veins. Analysis of
right ventricular function is particularly useful following a
large right ventricular infarction. Right ventricular systolic and
diastolic functions are difficult to assess, requiring parameters
obtained using two-dimensional echocardiography to be com-
bined with Doppler flow measurements of pulmonary, tricus-
pid and suprahepatic vein regurgitation flows.
Pulmonary pressures can be measured from the tricuspid
regurgitation or pulmonary regurgitation flow (continuous
Doppler). 
Right atrial pressure (RAP) is defined either empirically
(generally 10 mmHg) or from the diameter of the inferior vena
cava (IVC) and its respiratory variations.
Transoesophageal echocardiography is not used routinely
but is useful to assess ischaemic mitral regurgitation.
Stress echocardiography (table 5)
Dobutamine echocardiography
One of the most widely used indications for this technique is
the investigation of myocardial viability by stress, particularly
dobutamine stress echocardiography although this is however
at the cost of increased ventricular arrhythmias if LVEF is <25%
[23]. Several types of response have been described as predic-
ting subsequent functional recovery: viability only in the pre-
sence of segmental resting asynergy with increase in contrac-
tility at low doses (protocol limited to low dose or load): a
biphasic response, representing an improvement in myocar-
dial thickening at low dose (or low load in the exercise test)
with secondary deterioration in the same territory in response
to high doses of dobutamine or high load in the exercise test:
and sustained improvement, defined as an improvement in
myocardial thickening at low dose or load maintained at high
doses or high loads. Documenting contractile reserve, even
though not synonymous with cell viability [24], predicts func-
tional recovery after revascularisation with good accuracy,
particularly if extensive (>4 segments) [25] and is also a risk
marker for cardiovascular events [26]. The optimum time to
reassess left ventricular function after revascularisation and
the methods for doing this (echocardiography or other imaging
methods) are debated. It appears however that functional
(and LVEF) reassessment are indicated beyond the 5th month,
improvement being seen up to 14 months after revascularisa-
tion in one third of cases [27].
Left ventricular diastolic wall thickness measured by MRI or
echocardiography [7] is an excellent predictive indicator for
functional myocardial recovery (sensitivity 94% and specificity
48%) after revascularisation. Diastolic thickness <6 mm exclu-
des viability with excellent diagnostic accuracy.
The meta-analysis published by Bax [28] compared the dia-
gnostic performance of different imaging methods. This was
based on 32 studies which used dobutamine echocardiogra-
phy, 53 isotopic studies and 20 studies which used positron
emission topography (with 18-fluorodeoxyglucose); 11 studies
directly compared dobutamine echocardiography with an iso-
topic technique. The overall sensitivity of low dose or high
dose of dobutamine infusion was 81%, with a specificity of 80%
and negative predictive value of 89%; for low dose dobutamine
echocardiography, sensitivity was 82%, specificity 79% and the
Table 1 Chronic ischaemic heart disease: main parameters to record to analyse left ventricular morphology and
function.
Parameters Thresholds/quantification Technical comments Value
Segmental 
Wall motion
Qualitative or semi quantitative 
scoring scale (cf table)
16 or 17 segment model 
(ASE) [1]
Prognostic value of WMSI
Describe the number of abnormal 
segments
Segmental kinetics score (WMSI) [1]
2 parasternal views,
3 apical view, sub-costal view 
Wall thickness >6-mm thick: preserved 
<6-mm: fibrous scaring [7]
Measured in M-mode (difficult) No reversibility if fibrous 
scaring (fibrosis)
Left ventricular 
ejection fraction
(LVEF)
Visual analysis (avoid) Limitation of visual 
estimation
Modified Simpson biplane method 
(disc summation method) [1]
Harmonic imaging 
Apical 4 and 2 cavity views 
Reference method 
Limitations:
— risk of under-
estimating volumes 
— limited to 2 planes 
(use of real time 3D)
ASE: American Society of Echocardiography; WMSI: Wall motion score index.
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negative predictive value 83%. For high dose dobutamine
echocardiography (investigation for biphasic response or sus-
tained improvement), the corresponding values were 79, 85
and 90%. For thallium myocardial scintigraphy with reinjec-
tion, the values were 88, 50 and 83% respectively and for posi-
tron emission tomography, 93%, 58% and 86% respectively.
This meta-analysis confirmed that the isotopic techniques are
significantly more sensitive than dobutamine echocardiogra-
phy although the echocardiography method has higher specifi-
city and negative predictive value (p<0.005). The impact of
documenting viability on indications for revascularisation and
prognosis were described in the meta-analysis by Allman [26].
This included 24 studies on a total of 3088 patients who were
examined by dobutamine echocardiography (n=7), thallium
myocardial scintigraphy (n=6) or positron emission tomogra-
phy (n=11). LVEF ranged between 25 and 31% and viability was
found in 42% of cases; 35% of patients underwent revasculari-
sation with an average follow-up period of 25 months. The
mortality rate was significantly lower in the group with viabi-
lity when revascularisation was performed (mortality rate
3.2%/year compared to 16%/year, p<0.0001, reduction in rela-
tive risk 79.6%). There was no significant difference in the
annual mortality rate in the patient group with no detected
viability (6.2 and 7.7%/year respectively). The annual morta-
lity rate in the group which underwent revascularisation was
3.2% with viability compared to 7.7%/year without viability.
This rose to 16%/year in the medically treated group with via-
bility compared to 6.2%/year without, highlighting the “loss of
Table 2 Chronic ischaemic heart disease: other essential parameters to record.
Parameters Thresholds/
quantification
Technical comments Value
Mitral regurgitation 
(MR)
State presence or absence of MR, 
even if mild and mechanism 
Colour Doppler, 
apical approach 
Threshold for significant MR:
ERO >20 mm2 [17]
Quantification by PISA or 
Doppler volumetric 
techniques 
Adverse prognostic value in 
the absence of pre-existing 
valve disease 
Investigation 
for thrombus
State dimensions and features 
(sessile or pedunculated)
Harmonic imaging
Apical views showing the apex
False positives and negatives 
diagnosis possible
Cardiac output Low output <2.2L/min/m2 left ventricular outflow tract 
output
Haemodynamic consequence
Pericardium Topography and volume if 
effusion 
Multiple views Signs of intolerance (cavity 
collapse, respiratory flow 
variations)
PISA: proximal isovelocity surface area; ERO: effective regurgitant orifice
Table 3 Chronic ischaemic heart disease: essential parameters to record to analyse left ventricular filling [12-16].
Parameters Thresholds/quantification Technical comments Value
Mitral flow (at valve tip) Type 1: relaxation abnormality 
(E/A <1 before 50 years old 
and <0.5 after 50 years old
Filling flow has multi-
factorial dependency 
(age)
If LVH absent suggests filling 
pressures not raised 
Type 2: pseudo normal Use other indices 
(E/Ea, E/Vp, Pulmonary 
venous flow)
Type 3: restrictive 
E/A >2 and/or EDT <150ms 
If LVEF reduced suggests 
raised filling pressures 
Tissue Doppler at annulus E/Ea <8 Suggests filling pressures 
not raised 
E/Ea >15 Suggests filling pressures 
raised 
In post infarction, indepen-
dent prognostic value (mor-
tality)
E: transmitral E wave; Ea: tissue Doppler E wave at annulus; LVEF: left ventricular ejection fraction; LVH: left ventricular hypertrophy; 
EDT: E wave deceleration time; Vp: colour M-mode propagation velocity. 
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Table 4 Chronic ischaemic heart disease: essential parameters to record for the right heart.
Parameters Thresholds/
quantification
Technical comments Value
RV kinetics and function RV wall kinetics 
RV dilatation (RV/LV diameter 
ratio >0.6) 
Parasternal (short axis) apical 
(4C) and subcostal views
Pulmonary ejection flow Pulmonary output Accelera-
tion time 
Calculation of resistances 
[31]
Pulmonary regurgitation 
Doppler flow
PHT and Vmin/Vmax of PR
PAPm and PAPd
Coupled Doppler 
and Pedoff probe
PHT (PR) <150 ms and/or 
Vmin/Vmax <0.5 supports 
raised RVEDP and prognostic 
value
Tricuspid regurgitation 
Doppler flow
TRVmax 
TR morphology (raised RAP)
PAPs
Pulmonary resistances 
Multiple views and Pedoff 
probe
Vmax >2.5 m/s (take account 
age, body surface area)
Inferior vena cava Diameter and respiratory 
variations 
Subcostal 2D and TM mode IVC collapse <50% in favor
 of raised RAP 
LV: left ventricle; RV: right ventricle; TR: tricuspid regurgitation; PR: pulmonary regurgitation; PAPs: systolic pulmonary arterial pres-
sure; PAPm: mean pulmonary arterial pressure; PAPd: diastolic pulmonary arterial pressure; PHT: pressure half time; RAP: right atrial 
pressure; RVEDP: RV end-diastolic pressure; Vmin: minimal velocity; Vmax: maximum velocity; ICV: inferior vena cava.
Table 5 Chronic ischaemic heart disease: optional parameters to record for the left heart.
Parameters Thresholds/
quantification
Technical comments Value
Left ventricular morphology
Sphericity index [4] L/l ratio [4] Repeated assessment for 
remodelling 
(treatment evaluation protocols)
The lower this ratio the 
closer the LV appears as a 
sphere. (normal L/l ratio = 2)
LV at end-diastole and endsys-
tole divided by the volume of a 
sphere of identical diameter to 
the long axis of the LV [4]
Left ventricular 
opacification with 
contrast agent [10]
Harmonic imaging
Specific settings for the 
contrast agent 
Apical 4 and 2 cavity views 
Precise measurement of volu-
mes and LVEF
(treatment evaluation protocols)
Improved detection of the 
endocardium and measure-
ment of volumes and LVEF 
[10]
Stress echocardiography
Dobutamine 
echocardiography
WMSI at different steps 
LVEF at different steps
E/Ea
PAPs
Investigation for myocardial
viability involving at least 
4 segments
Excellent predictive value for 
functional recovery 
(NYHA, LVEF) and prognosis 
No use for mitral regurgitation
Exercise 
echocardiography
Mitral regurgitation (ERO), 
RV
E/Ea
PAPs
Area under the tent 
Standard protocol, 
semi-seated on bicycle 
Zoom on PISA
TR (Vmax)
Prognostic value 
(resting ERO >20mm2
and Δ exercise ERO >13 mm2 
[20]
E: transmitral E wave; Ea: tissue Doppler E wave at annulus; LVEF: left ventricular ejection fraction; L: length of LV in 4C apical view; 
l: LV width in 4C apical view; PAPs: systolic pulmonary arterial pressure; PISA: proximal isovelocity surface area; ERO: effective regurgi-
tant orifice; RV: regurgitated volume; TR: tricuspid regurgitation; WMSI: wall motion score index
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chance” when a decision is taken not to revascularise in the
presence of viability; this decision may be taken as a result of
coronary anatomy and/or risk factors or co-morbidities.
Exercise echocardiography 
Exercise echocardiography has only been used to a limited
extent in the investigation of ischaemic left ventricular systo-
lic dysfunction. The two-dimensional imaging acquisition pro-
tocol is classical (resting, low load, high load, recovery, for
the 2 parasternal and 3 apical views) with additional Doppler
acquisitions of the proximal isovelocity surface area of the
mitral regurgitation jet (zoom on PISA), the transmitral flow
by pulsed Doppler at the annulus and tricuspid regurgitation
for measurements of pulmonary artery systolic pressure in the
different stages of the exercise test. The degree of mitral
regurgitation under baseline conditions does not correlate at
all with the changes in mitral regurgitation during exercise,
which vary greatly from one patient to the other [18]. An
increase in the volume of mitral regurgitation on exercise is
seen in almost 80% of cases. A large increase (increase in the
effective regurgitant orifice area or ERO >13 mm2) is seen in
almost 30% of cases. When mitral regurgitation is severe at
Consensus indications for Doppler-echocardiography in the diagnosis and follow-up of chronic ischaemic heart disease 
Class I
— Assessment of new symptoms or cardiovascular physical signs in a patient with known coronary artery disease.
— Assessment of recovery of left ventricular function after revascularisation 
— Repeated echocardiographical assessment of left ventricular function when results are useful to guide treatment. 
Class II
— Follow-up in the absence of signs of progression in treated coronary artery disease patients in order to screen for 
deterioration in left ventricular function.
Class III
— Systematic repeated echocardiography in the absence of a change in clinical state in patients without left ventricular 
systolic dysfunction.
Consensus indications for exercise or pharmacological stress Doppler-echocardiography in the follow-up of chronic
ischaemic heart disease
Class I
— Assessment for changes in symptoms suggesting progression of coronary artery lesions when the exercise test is:
• impossible to perform (orthopaedic problem, arterial disease, elderly patients, etc.);
• uninterpretable (left ventricular hypertrophy, left bundle branch block, etc.);
• negative submaximal and therefore inconclusive;
• equivocal (ST segment depression limited in time and amplitude).
— Detection of restenosis after coronary angioplasty when the exercise test is:
• impossible to perform (orthopaedic problem, arterial disease, elderly patients, etc.);
• uninterpretable (left ventricular hypertrophy, left bundle branch block, etc.);
• negative submaximal and therefore inconclusive;
• equivocal (ST segment depression limited in time and amplitude).
— Identification of the topography and/or extension of myocardial ischaemia to decide on possible myocardial revascu-
larisation.
— Investigation of myocardial viability in the presence of reduced left ventricular systolic function to guide the decision 
for revascularisation.
— Coronary risk stratification before non-cardiac surgery in intermediate or high risk patients.
Class II
— Exercise echocardiography to estimate the volume and tolerability (pulmonary pressures) of moderate resting mitral 
regurgitation. 
— Dobutamine echocardiography to investigate for myocardial viability in the presence of reduced left ventricular systo-
lic dysfunction to consider the indication for cardiac resynchronisation. 
Class III
— Follow-up of a stable coronary artery disease patient able to perform a maximum exercise test. 
— Repeated investigation in a stable coronary artery disease patient without other cardiovascular symptoms.
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rest (ERO ≥20 mm2), the incidence rises to 40% and when the
leak is moderate it is 25% [26, 28, 29]. The large increase in
regurgitated volume is usually accompanied by a significant
rise in systolic pulmonary artery pressure and a fall in cardiac
output [18]. Increased left ventricular asynchronism occurs in
20-30% of patients and is accompanied by an increase in the
severity of mitral regurgitation [21, 30].
The dynamic nature of functional mitral regurgitation has
prognostic implications, [18-20], the validated threshold being
an increase of ≥13 mm2 in the ERO during the exercise test. If
the increase in ERO exceeds this threshold the relative risk of
death is increased by a factor of 5 during a 3 year follow-up
period. Analysis of dynamic changes in ERO may inform the
effectiveness of medical treatments and guide therapy. 
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ACUTE CORONARY SYNDROMES
The acute coronary syndromes (ACS) are a group of various cli-
nical situations ranging from unstable angina to ST segment
elevation with myocardial infarction. Echocardiography provi-
des important information in the diagnostic and prognostic
assessment of ACS. The versatility of echocardiography instru-
ments into coronary care units and the development of porta-
ble echocardiography instruments make this technique the
non-invasive imaging method of choice for emergency use,
which is readily available and easy to repeat at the patient’s
bedside.
Conditions for performing the investigation
High quality echocardiography imaging including second har-
monic imaging is required in order to obtain a reliable assess-
ment of myocardial wall motion and thickening.
Transthoracic echocardiography (TTE) is sufficient in the
great majority of cases to provide diagnostic information and
screen for complications. Transoesophageal echocardiography
(TEE) is rarely indicated and is used above all if a complication
is suspected but is not sufficiently assessed by transthoracic
echocardiography. Transoesophageal echocardiography requi-
res a trained operator.
Diagnostic utility
Echocardiography may be a valuable aid if the diagnosis is
uncertain, particularly when there is a high index of clinical
suspicion of ACS with a normal or non-contributory ECG [1-3].
Echocardiography is generally not useful diagnostically in ACS
with ST segment elevation and must not delay the institution
of reperfusion techniques.
The development of portable echocardiography instru-
ments allows the diagnosis to be confirmed rapidly if neces-
sary by finding typical regional wall motion abnormalities and
to screen for some complications (pericardial effusion, LV
thrombosis, right ventricular extension of inferior wall myo-
cardial infarction, mechanical complications) [4].
The parameters to be recorded are predominantly regional
wall motion abnormalities. These must be examined systema-
tically in all views. Their topography closely reflects the coro-
nary vascular distribution in the absence of some anatomical
variations [5] (figures 1 and 2). The presence of akinesia or
severe hypokinesia in a vascular territory is a very sensitive
marker of ischaemia [6]. The investigation must be performed
using the ASE 16 segment (or 17 segment) classification [7].
The thickness of walls with wall motion abnormalities must
be reported. Normal wall thickness argues in favour of an ACS
being recent.
Echocardiography is highly sensitive (90-95%), to diagnose
ischaemia and infarction in patients with a high probability of
ACS [1-3]. It also has a high negative predictive value (approxi-
mately 95%). Diagnostic false negatives nevertheless occur in
non-Q wave infarction. If ACS is suspected and the ECG is non-
contributory the sensitivity of echocardiography to diagnose
ischaemia is highest if the investigation is performed during
pain, particularly if the wall motion abnormalities regress
after the ischaemia is treated. 
The positive predictive value of echocardiography to dia-
gnose infarction is lower depending on the likelihood of the
diagnosis of ACS being present. Echocardiography must not be
used in isolation to diagnose myocardial infarction. Segmental
wall motion abnormalities are not specific for infarction or
acute ischaemia and may represent post-ischaemic myocar-
dial dysfunction (stunning), infarction scar or non-ischaemic
segmental abnormalities such as acute myocarditis.
Echocardiographical assessment of myocardial
infarction (ACS with ST segment elevation)
All patients with an acute infarction (with or without ST seg-
ment elevation) should have an echocardiogram performed
during the hospital phase. In some patients the investigation is
performed on an emergency basis for diagnostic purposes, if
an infarction is complicated by cardiogenic shock or if a
mechanical complication is suspected. In uncomplicated
infarction, echocardiography is generally performed after
reperfusion treatments. Echocardiography must be performed
immediately if a patient develops sudden haemodynamic
deterioration. Patients with extensive wall motion abnormali-
ties on the initial echocardiogram are at higher risk of deve-
loping complications. Repeated echocardiographic follow-up
is indicated in these patients. 
Parameters to be recorded [7]
Segmental wall motion
Echocardiography should describe the severity and extent of
segmental wall motion abnormalities reporting the number of
abnormal segments in the different views, results of exami-
ning for segmental abnormalities in the different territories or
for signs of previous infarction with wall thinning (table 1).
The severity of the wall motion involvement must be reported
for each segment, taking into account myocardial thickness:
akinesia (no wall thickening or endocardial movement), hypo-
kinesia (reduced wall thickening and endocardial movement),
or dyskinesia (paradoxical systolic movement associated with
absence of wall thickening). 
The ischaemic area may be over-estimated as adjacent seg-
ments may experience stretching, stunning or load modifica-
tions effects. 
Left ventricular morphology
Left ventricular dimensions are usually measured in M-mode in
parasternal views. Left ventricular volumes (particularly the
end-systolic volume) are measured when the left ventricular
ejection fraction (LVEF) is measured using the Simpson
method in apical views. 
Particular attention should be paid to geometrical changes
of expansion of the infarcted area, remodelling or the esta-
blishment of an early left ventricular aneurysm.
Left ventricular systolic function
Left ventricular systolic function is assessed by measuring the
LVEF using the Simpson biplane method. A segmental wall
motion score index (WMSI) is calculated from the sum of the
abnormal myocardial segmental kinetics scores as the ratio to
